Cellebrite Continues To Expect FY24 Revenue Of $370M-$380M, Est $376.126M
Portfolio Pulse from Benzinga Newsdesk
Cellebrite reaffirms its FY24 revenue guidance of $370M-$380M, aligning with the estimated $376.126M.
May 23, 2024 | 11:09 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cellebrite reaffirms its FY24 revenue guidance of $370M-$380M, which aligns with the market estimate of $376.126M.
Cellebrite's reaffirmation of its FY24 revenue guidance provides confidence to investors, as it aligns with market expectations. This positive outlook is likely to support the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100